Champions Oncology Inc expected to post a loss of 10 cents a share - Earnings Preview

Champions Oncology

04/09/2023 21:23

* Champions Oncology Inc  CSBR.OQ   CSBR.O  is expected
to show a
fall in quarterly revenue when it reports  results on September
6 (estimated). 
    * The Baltimore Maryland-based  company is expected to
report  a
5.0% decrease in revenue to $13.065 million from $13.75 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Champions Oncology
Inc is
for a loss of 10 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $9.5​, above​ its last closing price of $6.34.
​​​

This summary was machine generated September 4 at 20:23 GMT. 
All figures in US dollars  unless otherwise stated